Evidence map›Paper›PMID 18443232›Full record

ArticleHypertension (Dallas, Tex. : 1979)2008

Hepatocyte nuclear factor 1 and hypertensive nephropathy.

Renata I Dmitrieva, Cruz A Hinojos, Eric Boerwinkle, Michael C Braun, Myriam Fornage, Peter A Doris

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Hepatocyte Nuclear Factor-1Journal of the American Society of Nephrology : JASN · 2017
    Article
  3. Article
  4. Article
  5. Immunoglobulin locus associates with serum IgG levels and albuminuria.Journal of the American Society of Nephrology : JASN · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Renata I DmitrievaInstitute of Molecular Medicine, University of Texas HSC at Houston, TX 77030, USA.
Cruz A Hinojos
Eric Boerwinkle
Michael C Braun
Myriam Fornage
Peter A Doris
The University of Texas Health Science Center at Houston · USThe University of Texas at Austin · US

Funding

MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSIONR37HL051021 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 1999 to 2008
$10.8M
HNF1 transcriptional control of renal oxidative stressR01DK069632 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DORIS, PETER A · 2005 to 2009
$1.4M
CARDIOTONIC STEROIDS FROM THE ADRENAL GLANDR01DK045538 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DORIS, PETER A · 1994 to 2002
$697k
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSIONR01HL051021 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A · 1994 to 1998
–
NHLBI NIH HHS HL51021NHLBI NIH HHS R37 HL051021NIDDK NIH HHS R01 DK045538NIDDK NIH HHS R01 DK069632PHS HHS DDK45538PHS HHS DDK74680
6 · The paper itself

Abstract

Hypertension in spontaneously hypertensive rat (SHR) is associated with renal redox stress, and we hypothesized that nephropathy arises in SHR-A3 from altered capacity to mitigate redox stress compared with nephropathy-resistant SHR lines. We measured renal expression of redox genes in distinct lines of the spontaneously hypertensive rat (SHR-A3, SHR-B2, SHR-C) and the normotensive Wistar-Kyoto (WKY) strain. The SHR lines differ in either resisting (SHR-B2, SHR-C) or experiencing hypertensive nephropathy (SHR-A3). Immediately before the emergence of hypertensive renal injury expression of redox genes in SHR-A3 was profoundly altered compared with the injury-resistant SHR lines and WKY. This change appeared to arise in antioxidant genes where 16 of 28 were expressed at 34.3% of the level in the reference strain (WKY). No such change was observed in the injury-resistant SHR lines. We analyzed occurrence of transcription factor matrices in the promoters of the downregulated antioxidant genes. In these genes, the hepatocyte nuclear factor 1 (HNF1) transcription factor matrix was found to be nearly twice as likely to be present and the overall frequency of HNF1 sites was nearly 5 times higher, compared with HNF1 transcription factor matrices in antioxidant genes that were not downregulated. We identified 35 other (nonredox) renal genes regulated by HNF1. These were also significantly downregulated in SHR-A3, but not in SHR-B2 or SHR-C. Finally, expression of genes that comprise HNF1 (Tcf1, Tcf2, and Dcoh) was also downregulated in SHR-A3. The present experiments uncover a major change in transcriptional control by HNF1 that affects redox and other genes and precedes emergence of hypertensive renal injury.

Indexed as

Animal FeedAnimalsBlood PressureGene Expression ProfilingHepatocyte Nuclear Factor 1Hypertension, RenalKidneyMaleOxidation-ReductionOxidative StressRatsRats, Inbred SHRRats, Inbred WKYTranscription, GeneticHepatocyte Nuclear Factor 1

Identifiers

PMID18443232
PMCPMC2840399
OpenAlexW2112731724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.